Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shantan Reddy

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Mbio|August 24, 2022
Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in PennsylvaniaAndrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
The Journal of Clinical Investigation|December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integrationChristopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15Gengwen Tian, Amy N Courtney, Hangjin Yu, et al.
The New England Journal of Medicine|May 13, 2026
Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector DeliveryRebecca C Ahrens-Nicklas, Chelsea Kotch, Aoife M Roche, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Signatures of COVID-19 severity and immune response in the respiratory tract microbiomeCarter Merenstein, Guanxiang Liang, Samantha A Whiteside, et al.
Mbio|August 31, 2022
Correction for Merenstein et al., "Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome"Carter Merenstein, Guanxiang Liang, Samantha A Whiteside, et al.
Mbio|August 17, 2021
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract MicrobiomeCarter Merenstein, Guanxiang Liang, Samantha A Whiteside, et al.
Nature Medicine|January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trialFarid Boulad, Aurelio Maggio, Xiuyan Wang, et al.
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
Mbio|February 8, 2022
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021Andrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Mbio|August 24, 2022
Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in PennsylvaniaAndrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
The Journal of Clinical Investigation|December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integrationChristopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15Gengwen Tian, Amy N Courtney, Hangjin Yu, et al.
The New England Journal of Medicine|May 13, 2026
Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector DeliveryRebecca C Ahrens-Nicklas, Chelsea Kotch, Aoife M Roche, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Signatures of COVID-19 severity and immune response in the respiratory tract microbiomeCarter Merenstein, Guanxiang Liang, Samantha A Whiteside, et al.
Mbio|August 31, 2022
Correction for Merenstein et al., "Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome"Carter Merenstein, Guanxiang Liang, Samantha A Whiteside, et al.
Mbio|August 17, 2021
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract MicrobiomeCarter Merenstein, Guanxiang Liang, Samantha A Whiteside, et al.
Nature Medicine|January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trialFarid Boulad, Aurelio Maggio, Xiuyan Wang, et al.
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
Mbio|February 8, 2022
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021Andrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
Pageof 7